http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2402348-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78e89e670c0ef311469e46d65e6872a7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab4163b778a4c1d10ae91da8ead0a82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94db06cac2dfe51c62276c2cf32cebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d072f26c85dcef3ff8a661a0a7fbd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395396c2e93cdaa7346843171870901c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86dd0c45f01306cbba5f41e96acf96b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df952eadd8ef27597a78b85a46819acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3f5eace35d9af35f92ed8e22e4dbb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_250f93dc96fd2ea5edfd7a46069603c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e16a6c4ab40f655b4edb797793539ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bfaf162fcb4db91f2b03d03730cd57d
publicationDate 2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2402348-C1
titleOfInvention Dry rabies vaccine for cattle and small cattle
abstract FIELD: medicine, veterinary science. n SUBSTANCE: invention refers to biotechnology. The vaccine contains an inactivated rabies antigen, a culture medium, a shielding desiccation medium of peptone, sucrose and gelatin, and also an immunity stimulator saponin. The desiccation environment in addition contains aluminium oxide hydrate in the following ratio in an end product (wt %): aluminium oxide hydrate with adsorbed inactivated rabies virus - 6.0-9.0, saponin - 0.75-1.5, peptone - 30.0-33.0, sucrose - 35.0-37,0, gelatin - 9.0-10.0, culture medium - the rest. n EFFECT: dry vaccine exhibits high level of immunogenic activity. n 3 tbl
priorityDate 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6915893
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454383917
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453685668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2365
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11292

Total number of triples: 35.